Myths vs facts: FOXO3 and blood sugar

The FOXO3 gene variant (e.g., rs2801935) is frequently linked to longevity and insulin signaling, but its direct impact on blood sugar is minimal. GWAS studies show weak associations with insulin resistance, but effect sizes are very small (<1% variance explained). Myth: A FOXO3 SNP determines your blood sugar control. Fact: Lifestyle factors (diet, exercise) overwhelmingly dominate. Direct-to-consumer tests often overstate the importance. No evidence supports personalized supplementation or diet changes based solely on this variant. Evidence: human-gwas. Caveat: No randomized trials or clinical guidelines exist.